No black box warning on record for Lisinopril/hctz

As of the latest FDA labeling reviewed, Lisinopril/hctz (LISINOPRIL/HCTZ) does not carry a black box warning. Standard warnings and precautions still apply — see the full Lisinopril/hctz medicine page for the complete safety profile.

Other warnings & precautions

General Lisinopril Anaphylactoid and Possibly Related Reactions: Presumably because angiotensin-converting enzyme inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors (including lisinopril and hydrochlorothiazide tablets) may be subject to a variety of adverse reactions, some of them serious. Head and Neck Angioedema:

No black box warning on record for Lisinopril/hctz

Other warnings & precautions

General Lisinopril Anaphylactoid and Possibly Related Reactions: Presumably because angiotensin-converting enzyme inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors (including lisinopril and hydrochlorothiazide tablets) may be subject to a variety of adverse reactions, some of them serious. Head and Neck Angioedema:

Lisinopril/hctz Black Box Warning

No black box warning on record for Lisinopril/hctz

Other warnings & precautions

Lisinopril/hctz Black Box Warning

No black box warning on record for Lisinopril/hctz

Other warnings & precautions